A human genome can now be sequenced in a few days for a few thousand dollars. As a result, new classes of drugs are under development to combat diseases for which no treatments exist. A revolution in biotech is coming to fruition, making them a rare bright spot in an otherwise slow-growth economy.
from Forbes Real Time //www.forbes.com/sites/kenkam/2017/09/04/the-biotech-revolution-comes-to-fruition-for-investors/
via IFTTT
No comments:
Post a Comment